Evaluating a Therapeutic Agent That May Inhibit a Protein Associated with Lymphoma
This study evaluates a new therapeutic agent designed to inhibit the survivin protein in canine lymphoma.
This study evaluates a new therapeutic agent designed to inhibit the survivin protein in canine lymphoma.
This study investigates the role of citrullination in canine mammary cancer and how interfering with this process might lead to more effective anticancer treatments.
This study will determine the genetic and functional differences of eight genes that are strongly associated with congenital extrahepatic portosystemic shunts in several small dog breeds.
This study investigates the effects of topical ophthalmic prednisolone (steroid) and diclofenac (nonsteroidal anti-inflammatory drug) on diabetes mellitus regulation in client-owned dogs.
This study investigates a new therapeutic target (valosin-containing protein) for dogs with lymphoma.
This fellowship investigates genetic lesions in canine mast cell tumors using cytogenetic and expression analysis.
This fellowship study investigates how incorporating cooked dry bean powders into a canine kibble diet alters inflammation and metabolism and thereby reduces the risk of obesity and potentially of cancer.
This study will use high throughput DNA sequencing methods to characterize the bacteria found on mammalian companion animals and their human household members, with an emphasis on methicillin-resistant Staphylococcus species.
This study investigates the therapeutic relevance of targeting the Wnt signaling pathways in canine malignant melanoma.
The aim of this study is to discover drugs that will work against cancer stem cells of an insulin-producing endocrine pancreatic tumor (insulinoma), thereby improving the prognosis of dogs suffering from insulinoma.